Lyra Therapeutics Inc. (LYRA)
Lyra Therapeutics Statistics
Share Statistics
Lyra Therapeutics has 1.33M shares outstanding. The number of shares has increased by -0.59% in one year.
| 1.33M |
| -0.59% |
| 0.65% |
| 41.07% |
| n/a |
| 113 |
| 0.02% |
Short Selling Information
The latest short interest is 7.33M, so 11.06% of the outstanding shares have been sold short.
| 7.33M |
| 11.06% |
| 13.84% |
| 1 |
Valuation Ratios
The PE ratio is -0.14 and the forward PE ratio is -0.81. Lyra Therapeutics's PEG ratio is -0.01.
| -0.14 |
| -0.81 |
| 8.76 |
| 0.3 |
| 1.16 |
| -0.19 |
| -0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Lyra Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 3.41, with a Debt / Equity ratio of 2.97.
| 3.41 |
| 3.41 |
| 2.97 |
| -0.57 |
| -0.48 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $51,133.33 |
| $-3,114,500 |
| 30 |
| 0.02 |
| n/a |
Taxes
| 39K |
| -0.04% |
Stock Price Statistics
The stock price has increased by 57.62% in the last 52 weeks. The beta is 0.01, so Lyra Therapeutics's price volatility has been higher than the market average.
| 0.01 |
| 57.62% |
| 6.66 |
| 10.02 |
| 74.78 |
| 602,758 |
Income Statement
In the last 12 months, Lyra Therapeutics had revenue of 1.53M and earned -93.44M in profits. Earnings per share was -71.5.
| 1.53M |
| 1.06M |
| -96.35M |
| -93.44M |
| -60.26M |
| -60.73M |
| -71.5 |
Balance Sheet
The company has 40.58M in cash and 34.38M in debt, giving a net cash position of 6.2M.
| 40.58M |
| 34.38M |
| 6.2M |
| -404.79M |
| 56.32M |
| 22.43M |
Cash Flow
In the last 12 months, operating cash flow was -70.01M and capital expenditures -2.34M, giving a free cash flow of -72.35M.
| -70.01M |
| -2.34M |
| -72.35M |
| -55.56 |
Margins
Gross margin is 69.3%, with operating and profit margins of -6280.83% and -6090.94%.
| 69.3% |
| -6280.83% |
| -6088.4% |
| -6090.94% |
| -3928.42% |
| -6280.83% |
| -4716.36% |
Dividends & Yields
LYRA does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for LYRA is $100, which is 296.5% higher than the current price. The consensus rating is "Hold".
| $100 |
| 296.5% |
| Hold |
| 2 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on May 28, 2025. It was a backward split with a ratio of 1:50.
| May 28, 2025 |
| backward |
| 1:50 |
Scores
| -12.1 |
| 3 |